Skip to content

Usefulness of combination of microneedling with dermaroller and chemical peels in treatment of acne scars

A Comparative study of microneedling with 15% trichloroacetic acid peel versus microneedling with 25% pyruvic acid peel in acne scars

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022996
Enrollment
30
Registered
2020-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L905- Scar conditions and fibrosis of skin

Interventions

Intervention1: microneedling with chemical peels: microneedling on both sides of face with 15% TCA on one side and 25% pyruvic acid peel on other side of randomly selected patients of acne scars Contr

Sponsors

Bhawna Solanki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with facial atrophic acne scars Patients of age 18 years or more

Exclusion criteria

Exclusion criteria: Patients with history or tendency to develop keloid/hypertrophic scars Patients with active acne Patients who have undergone any skin resurfacing procedure within preceding 1 year Pregnant subjects Active herpes simplex in treatment area Immunocompromised patients Patients with history of bleeding diathesis or coagulation defects Recent (

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of microneedling with 15% TCA and 25% pyruvic acid peels in management of post acne scarringTimepoint: Better improvement in Acne scar severity grading at the end of 21 weeks

Secondary

MeasureTime frame
To assess patient satisfaction with microneedling using 15% TCA and 25% pyruvic acid in management of post acne scarringTimepoint: Better patient satisfaction with microneedling using 15% TCA and 25% pyruvic acid in management of acne scar at the end of 21 weeks

Countries

India

Contacts

Public ContactBhawna Solanki

Delhi university

rashmisarkar@gmail.com9818244340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026